‹ ›
MYP_120227
← PREVIOUS NEXT → BACK
Basic Information
FBP2
Antimicrobial
Antiviral
Antiviral ▸ Anti-Influenza virus ▸ Anti-Influenza A ▸ Anti-Influenza A virus
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
Standard
16 amino acids
C85H132N34O20S
Standard
Sequence
RGAHIKGRWDSRCHRF
Physicochemical Analysis
1982.24 Da
11.54
3.92
3.60
0.2453
-1.42
0.44
-0.52
90.56
30.62
0.1250
5500.00
5500.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
904.12
-9.52
36.0
27.0
65.0
140.0
5.0
15.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0019861 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral
H1N1
PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
RECORD: Rec_0205836 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
influenza A virus(H1N1)
PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
RECORD: Rec_0370446 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/
RECORD: Rec_0377292 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-Influenza A virus Fusion inhibition
Influenza A virus (H1N1) | MDCK cells
25.22 μM
% inhibition
Mammalian: 1 h; Yeast: 2 min; E. coli: 2 min
PaperFusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants. | Zhao H, Meng X, Peng Z, Lam H, Zhang C, Zhou X, Chan JF, Kao RYT, To KK, Yuen KY. | Emerg Microbes Infect. 2022 Dec;11(1):926-937. | DOI:10.1080/22221751.2022.2051753 | PMID:35259078 PMID35259078 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/35259078/